ATE237589T1 - Catecholdiether-derivate verwendbar als pharmazeutische mittel - Google Patents
Catecholdiether-derivate verwendbar als pharmazeutische mittelInfo
- Publication number
- ATE237589T1 ATE237589T1 AT95923739T AT95923739T ATE237589T1 AT E237589 T1 ATE237589 T1 AT E237589T1 AT 95923739 T AT95923739 T AT 95923739T AT 95923739 T AT95923739 T AT 95923739T AT E237589 T1 ATE237589 T1 AT E237589T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- pharmaceutical agents
- date
- pde
- tnf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dental Preparations (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/007208 WO1996040636A1 (en) | 1995-06-07 | 1995-06-07 | Catechol diethers derivatives useful as pharmaceutical agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE237589T1 true ATE237589T1 (de) | 2003-05-15 |
Family
ID=22249266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95923739T ATE237589T1 (de) | 1995-06-07 | 1995-06-07 | Catecholdiether-derivate verwendbar als pharmazeutische mittel |
Country Status (11)
Country | Link |
---|---|
US (1) | US6028086A (de) |
EP (1) | EP0869945B1 (de) |
JP (1) | JP3410104B2 (de) |
AT (1) | ATE237589T1 (de) |
CA (1) | CA2223245C (de) |
DE (1) | DE69530429T2 (de) |
DK (1) | DK0869945T3 (de) |
ES (1) | ES2193196T3 (de) |
FI (1) | FI114468B (de) |
PT (1) | PT869945E (de) |
WO (1) | WO1996040636A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9903919D0 (en) * | 1999-02-19 | 1999-04-14 | Darwin Discovery Ltd | Aminophenols and their therapeutic use |
EA006685B1 (ru) | 1999-08-21 | 2006-02-24 | Алтана Фарма Аг | Синергетическая композиция |
EP2258689A1 (de) * | 2000-03-16 | 2010-12-08 | Biolipox AB | Benzylierte PDE4-Inhibitoren |
KR20040010713A (ko) * | 2001-06-15 | 2004-01-31 | 야마노우치세이야쿠 가부시키가이샤 | 페닐피리딘 카보닐 피페라진 유도체 |
EP1559716B1 (de) | 2002-11-06 | 2011-09-14 | ASKA Pharmaceutical Co., Ltd. | Pyrazolonaphthyridinderivat |
US9463426B2 (en) * | 2005-06-24 | 2016-10-11 | Boston Scientific Scimed, Inc. | Methods and systems for coating particles |
KR20080046728A (ko) | 2005-09-15 | 2008-05-27 | 아스카 세이야쿠 가부시키가이샤 | 복소환 화합물, 그의 제조 방법 및 용도 |
CA2858520A1 (en) * | 2006-05-18 | 2007-11-29 | Pharmacyclics Inc. | Intracellular kinase inhibitors |
EP2196465A1 (de) | 2008-12-15 | 2010-06-16 | Almirall, S.A. | (3-oxo)pyridazin-4-ylurea-Derivate als PDE4 Hemmern |
EP2226323A1 (de) | 2009-02-27 | 2010-09-08 | Almirall, S.A. | Neuartige Tetrahydropyrazol[3,4-c]isochinolin-5-amin-Derivate |
EP2380890A1 (de) | 2010-04-23 | 2011-10-26 | Almirall, S.A. | Neue 7,8-Dihydro-1,6-Naphthyridin-5(6H)-on-Derivate als PDE4 Inhibitoren |
EP2394998A1 (de) | 2010-05-31 | 2011-12-14 | Almirall, S.A. | 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl Derivate als PDE4 Inhibitoren |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE71647B1 (en) * | 1991-01-28 | 1997-02-26 | Rhone Poulenc Rorer Ltd | Benzamide derivatives |
GB9315595D0 (en) * | 1993-07-28 | 1993-09-08 | Res Inst Medicine Chem | New compounds |
-
1995
- 1995-06-07 US US08/973,725 patent/US6028086A/en not_active Expired - Fee Related
- 1995-06-07 WO PCT/US1995/007208 patent/WO1996040636A1/en active IP Right Grant
- 1995-06-07 DK DK95923739T patent/DK0869945T3/da active
- 1995-06-07 PT PT95923739T patent/PT869945E/pt unknown
- 1995-06-07 EP EP95923739A patent/EP0869945B1/de not_active Expired - Lifetime
- 1995-06-07 CA CA002223245A patent/CA2223245C/en not_active Expired - Fee Related
- 1995-06-07 AT AT95923739T patent/ATE237589T1/de not_active IP Right Cessation
- 1995-06-07 ES ES95923739T patent/ES2193196T3/es not_active Expired - Lifetime
- 1995-06-07 JP JP50037397A patent/JP3410104B2/ja not_active Expired - Fee Related
- 1995-06-07 DE DE69530429T patent/DE69530429T2/de not_active Expired - Fee Related
-
1997
- 1997-12-05 FI FI974442A patent/FI114468B/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0869945T3 (da) | 2003-07-14 |
DE69530429D1 (de) | 2003-05-22 |
CA2223245A1 (en) | 1996-12-19 |
EP0869945B1 (de) | 2003-04-16 |
US6028086A (en) | 2000-02-22 |
FI974442A0 (fi) | 1997-12-05 |
JP3410104B2 (ja) | 2003-05-26 |
WO1996040636A1 (en) | 1996-12-19 |
CA2223245C (en) | 2002-05-21 |
FI974442A (fi) | 1997-12-05 |
JP2001527508A (ja) | 2001-12-25 |
EP0869945A1 (de) | 1998-10-14 |
PT869945E (pt) | 2003-09-30 |
FI114468B (fi) | 2004-10-29 |
ES2193196T3 (es) | 2003-11-01 |
MX9709869A (es) | 1998-03-31 |
DE69530429T2 (de) | 2003-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971811L (no) | Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler | |
CA2166721A1 (en) | Bicyclic tetrahydro pyrazolopyridines | |
DK0738270T3 (da) | Dihydropyrazolopyrroler | |
AP2002002589A0 (en) | Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes. | |
ATE234270T1 (de) | Cathecoldiether als selektive pde iv hemmungsmittel | |
ATE237589T1 (de) | Catecholdiether-derivate verwendbar als pharmazeutische mittel | |
MXPA05010958A (es) | Derivados indazol como inhibidores jnk. | |
JP2006503048A5 (de) | ||
ATE284860T1 (de) | Neue verwendung von phenylheteroalkylamin- derivaten | |
MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
GEP20033029B (en) | Substituted 1,8-Naphthyridin-4(1H)-Ones as Phosphodiesterase 4 Inhibitors | |
JP2006512293A5 (de) | ||
WO2002085861A8 (en) | Imidazolidine compounds and their use as cxcr3 antagonists | |
MY116527A (en) | Tricyclic 5, 6-dihydro-9h-pyrazolo [3,4,-c]-1,2,4- triazolo [4,3-a] pyridines | |
ATE389655T1 (de) | Pyrimidinderivate | |
WO1999018099B1 (en) | Aryl thiophene derivatives as pde iv inhibitors | |
ATE294572T1 (de) | Verwendung von gepirone metabolite zur erstellungs eines medicaments zur behandlung von neurologischer krankheiten | |
ATE265428T1 (de) | Neue verwendung von phenylheteroalkylamin- derivaten | |
ATE254616T1 (de) | Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0869945 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |